UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 99

Sortiert nach

Current anti-myeloma therapies in renal manifestations of monoclonal light chain-associated Fanconi syndrome: a retrospective series of 49 patients

Leukemia, 2017-01, Vol.31 (1), p.123-129

2017

Volltextzugriff (PDF)

Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib

Nephrology, dialysis, transplantation, 2009-02, Vol.24 (2), p.682-685

2009

Volltextzugriff (PDF)

Recurrent 2,8‐Dihydroxyadenine Nephropathy: A Rare but Preventable Cause of Renal Allograft Failure

American journal of transplantation, 2014-11, Vol.14 (11), p.2623-2632

2014

Volltextzugriff (PDF)

Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes

Journal of the American Society of Nephrology, 2002, Vol.13 (1), p.65-74

2002

Volltextzugriff (PDF)

Therapeutic mTOR Inhibition in Autosomal Dominant Polycystic Kidney Disease: What Is the Appropriate Serum Level?

American journal of transplantation, 2010-07, Vol.10 (7), p.1701-1706

2010

Volltextzugriff (PDF)

POS-496 INTERIM ANALYSIS OF THE EAGLE TRIAL: AN OPEN-LABEL STUDY TO ASSESS THE LONG-TERM SAFETY AND TOLERABILITY OF BARDOXOLONE METHYL IN PATIENTS WITH ALPORT SYNDROME

Kidney international reports, 2021-04, Vol.6 (4), p.S214-S215

2021

Volltextzugriff (PDF)

Unexplicated hyperammonemic encephalopathy: remember the old urinary diversions

Acta neurologica Belgica, 2016-12, Vol.116 (4), p.677-678

2016

Volltextzugriff (PDF)

The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity

Molecular and Cellular Biology, 1997-09, Vol.17 (9), p.5629-5639

1997

Volltextzugriff (PDF)

Eculizumab for Atypical Hemolytic Uremic Syndrome Recurrence in Renal Transplantation

American journal of transplantation, 2012-12, Vol.12 (12), p.3337-3354

2012

Volltextzugriff (PDF)

Post-allogeneic haematopoietic stem cell transplantation membranous nephropathy: clinical presentation, outcome and pathogenic aspects

Nephrology, dialysis, transplantation, 2007-05, Vol.22 (5), p.1369-1376

2007

Volltextzugriff (PDF)

Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study

Blood, 2019-02, Vol.133 (6), p.576-587

2019

Volltextzugriff (PDF)

Cystinuria: clinical practice recommendation

Kidney international, 2021-01, Vol.99 (1), p.48-58

2021

Volltextzugriff (PDF)

Collagen α5 and α2(IV) chain coexpression: Analysis of skin biopsies of Alport patients

Kidney international, 2007-08, Vol.72 (4), p.512-516

2007

Volltextzugriff (PDF)

Thalidomide in patients with multiple myeloma and renal failure

British journal of haematology, 2004-04, Vol.125 (1), p.96-97

2004

Volltextzugriff (PDF)

Monoallelic pathogenic ALG5 variants cause atypical polycystic kidney disease and interstitial fibrosis

American journal of human genetics, 2022-08, Vol.109 (8), p.1484-1499

2022

Volltextzugriff (PDF)

Splice-mediated insertion of an Alu sequence in the COL4A3 mRNA causing autosomal recessive Alport syndrome

Human molecular genetics, 1995-04, Vol.4 (4), p.675-679

1995

Volltextzugriff (PDF)

Effects of Bardoxolone Methyl in Alport Syndrome

Clinical journal of the American Society of Nephrology, 2022-12, Vol.17 (12), p.1763-1774

2022

Volltextzugriff (PDF)

Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome

American journal of nephrology, 2021-05, Vol.52 (3), p.180-189

2021

Volltextzugriff (PDF)

Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies

Nature reviews. Nephrology, 2012-11, Vol.8 (11), p.643

2012

Volltextzugriff (PDF)

Efficacy and safety of an innovative prolonged-release combination drug in patients with distal renal tubular acidosis: an open-label comparative trial versus standard of care treatments

Pediatric nephrology (Berlin, West), 2021-01, Vol.36 (1), p.83-91

2021

Volltextzugriff (PDF)

085 Hypohidrosis, ichthyosis and hypokalemia: HELIX syndrome

Journal of investigative dermatology, 2021-10, Vol.141 (10), p.S163-S163

2021

Volltextzugriff (PDF)

Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome

Journal of medical genetics, 2007-03, Vol.44 (3), p.193-199

2007

Volltextzugriff (PDF)

Spectrum of mutations in the COL4A5 collagen gene in X-linked Alport syndrome

American journal of human genetics, 1996-12, Vol.59 (6), p.1221-1232

1996

Volltextzugriff (PDF)

Endostatin Induces Endothelial Cell Apoptosis

The Journal of biological chemistry, 1999-04, Vol.274 (17), p.11721-11726

1999

Volltextzugriff (PDF)

X-linked Alport syndrome: Natural history and genotype-phenotype correlations in girls and women belonging to 195 families: A European Community Alport Syndrome Concerted Action Study

Journal of the American Society of Nephrology, 2003-10, Vol.14 (10), p.2603-2610

2003

Volltextzugriff (PDF)

1 – 25 von 99

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(89)

Publikationsform

Artikel
(97)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(65)
Science & Technology
(64)
Life Sciences & Biomedicine
(63)
Female
(37)
Male
(36)
Urology & Nephrology
(34)
Biological And Medical Sciences
(29)
Adult
(28)
Medical Sciences
(28)
Nephrology. Urinary Tract Diseases
(24)
Middle Aged
(20)
Nephropathies. Renovascular Diseases. Renal Failure
(17)
Glomerulonephritis
(16)
Adolescent
(15)
Nephritis, Hereditary - Genetics
(15)
Life Sciences
(12)
Aged
(11)
Mutation
(11)
Transplantation
(11)
Collagen - Genetics
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Current anti-myeloma therapies in renal manifestations of monoclonal light chain-associated Fanconi syndrome: a retrospective series of 49 patients

Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib

Recurrent 2,8‐Dihydroxyadenine Nephropathy: A Rare but Preventable Cause of Renal Allograft Failure

Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes

Therapeutic mTOR Inhibition in Autosomal Dominant Polycystic Kidney Disease: What Is the Appropriate Serum Level?

POS-496 INTERIM ANALYSIS OF THE EAGLE TRIAL: AN OPEN-LABEL STUDY TO ASSESS THE LONG-TERM SAFETY AND TOLERABILITY OF BARDOXOLONE METHYL IN PATIENTS WITH ALPORT SYNDROME

Unexplicated hyperammonemic encephalopathy: remember the old urinary diversions

The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity

Eculizumab for Atypical Hemolytic Uremic Syndrome Recurrence in Renal Transplantation

Post-allogeneic haematopoietic stem cell transplantation membranous nephropathy: clinical presentation, outcome and pathogenic aspects

Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study

Cystinuria: clinical practice recommendation

Collagen α5 and α2(IV) chain coexpression: Analysis of skin biopsies of Alport patients

Thalidomide in patients with multiple myeloma and renal failure

Monoallelic pathogenic ALG5 variants cause atypical polycystic kidney disease and interstitial fibrosis

Splice-mediated insertion of an Alu sequence in the COL4A3 mRNA causing autosomal recessive Alport syndrome

Effects of Bardoxolone Methyl in Alport Syndrome

Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome

Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies

Efficacy and safety of an innovative prolonged-release combination drug in patients with distal renal tubular acidosis: an open-label comparative trial versus standard of care treatments

085 Hypohidrosis, ichthyosis and hypokalemia: HELIX syndrome

Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome

Spectrum of mutations in the COL4A5 collagen gene in X-linked Alport syndrome

Endostatin Induces Endothelial Cell Apoptosis

X-linked Alport syndrome: Natural history and genotype-phenotype correlations in girls and women belonging to 195 families: A European Community Alport Syndrome Concerted Action Study

Suchergebnisse filtern